Dose-Dependent Pharmacokinetics of Amphotericin B Lipid Complex in Rabbits
Amphotericin B lipid complex (ABLC) was recently approved by the Food and Drug Administration for treatment of patients with invasive fungal infections who are intolerant of or refractory to conventional amphotericin B therapy. Little is known, however, about the pharmacokinetics of this new antifun...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphov: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
2000
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90015/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10898677/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.8.2068-2076.2000 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
